Open original FDA record ↗Recall record
- FDA identifier
- Z-1852-2013
- Company in FDA record
- Hospira Inc.
- FDA classification date
- Aug 5, 2013
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
It was discovered that there was a potential for the piercing pin on certain Hospira blood sets to puncture the outer wall of blood bags during insertion of the pin into the blood bag.
Source facts
- Action
- Hospira sent an Important Safety Information letter dated April 1, 2013, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to exercise EXTREME CAUTION when using Hospira blood bags and to make sure that all instructions for use are included with the blood bag and their facility's protocol for spiking blood bags are completely followed in order to minimize the possibility of puncturing the outer wall of the blood bag. Customers with issues were instructed to call Hospira at 1-800-441-4100 or email ProductComplaintsPP@hospira.com. Customers were asked to complete the attached replay formand return it to the fax number on the form. If customers distributed the product further they were instructed to notify their accounts that received the affected product and ask them to contact Stericycle at 1-866-608-3936 to receive a reply form. Customers with questions were instructed to contact Hospira at 1-800-441-4100. For questions regarding this recall call 224-212-2000.
- Initiated
- 2013-04-01
- Root cause
- Device Design
- Terminated
- 2017-05-24
- Distribution
- Worldwide Distribution - USA (nationwide) and Puerto Rico and Internationally to Costa Rica.
- Recall number
- Z-1852-2013
- Recall status
- Terminated
- CDRH record ID
- 119885
- FDA classified
- 2013-08-05
- Recall event number
- 65689